The sunpharma has breaked its 7 years high and may test its ATH which is at 1200. Fundamentals are also good. The promoters has unpledged 1.51% of shares. The volume is also good and the daily delivery is 67% while the 6 months average is only 54.
Strides pharma's financials has been improved and the chart is showing that the stock is at huge supple zone which we can see in delivery % of today also which is 59.5%.
